Scheduled maintenance will begin on May 30th, 2025. Server will be temporarily unavailable — learn more.
current user: public

If you have questions about the server, please let us know.

Query: [TU] KOG3895 Synaptic vesicle protein Synapsin, from COG1018

Results of FFAS03 search in COG1018
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .  630    .  640    .  650    .  660    .  670    .  680    .  690    .  700    .  710    .  720    .  730    .  740    .  750    .  760    .  770    .  780    .  790    .  800    .  810    .  820    .  830    .  840    .  850    .  860    .  870    .  880    .  890    .  900    .  910    .  920    .  930    .  940    .  950    .  960    .  970    .  980    .
# Score Template Links and tools%idFirst MPPPPAPGQPAGAAPELSLSFGAGKTPATAAPAPPRGVSAPTSPAKSRESLLQRVQSLTGAARDQGASILGAAVQSATQRAPAFSKDKYFTLLVLDDQNTDWSKYFRGRRLHGDFDIRVEQAEFRDITVVSSADTGPVVTMAAYRSGTRVARSFRPDFVLIRQPPRDGSSDYRSTILGLKYGGVPSINSLHSIYQFQDKPWVFSHLLQLQRRLGRDGFPLIEQTFFPNPRDLVSIRGMMWRTHVLLLRSCFISYSMLHLQHVAIICIPDPVTPPHYRSTRRETFFLSVHLQFQFTKFPSVLKAGHCHGGVATARLENQSALQDAAGLVSGAGNDSHCYCTIEPYIDAKFSVHIQKIGNNYKAFMRKSITGNWKTNQGSAMLEQITLTEKYKSWVDEISELFGGMEVCGLSVVVAKDGREYIISACDSTFALIGDTQEEDRRQIADLVSGRMQNVCRPSMAQTGPGKLPSRSSVSSRAESPTDEGVAPTPPLPAGPRPAPMGGPPPIPERTSPAVGSIGRLSSRSSISEVPEEPSSSGPSTVGGEIANKKRGRTASETSSGSGPGSVPSSAGPGSGFSSSFLGKQFSFAGKGEGVISTQPTQRPSEEPPAIPTTASSAVRPESSVSVSDSRNTDTLTERAGAGYQPVTNYEQQERVNPFDKEPSKSGSAASIHTSSSSSISSSSISSRINRNGNAIQSPPPPAGPPPPPPTNVTAVGSNANSSSGYRNSFSSSLSKDKTSYGNYGSTTSVETITRMDTNTTNIGATATEAGEASGVTAITNISNSDGIVAPTTGTITTSVTTNDWRSAIGMRSASVYSAPAAVTTVLPGDTSGYDSNSIASQGEGLNNPSDLPSYTRPSYSRSESNASKHSDLDVIFGDSKTTPASYGNGKYTRAAGSISDADMIFGGPPSNYKTDRFGASKSMSMTSGGVGSGNGSGSGLGGYKIYDSIQNAAFSDFSDSGSMSSIGSHTKRWSASKEEDDELDLKLast
1 -223.000[TU] KOG3895 Synaptic vesicle protein Synapsin  ali  100  1MPPPPAPGQPAGAAPELSLSFGAGKTPATAAPAPPRGVSAPTSPAKSRESLLQRVQSLTGAARDQGASILGAAVQSATQRAPAFSKDKYFTLLVLDDQNTDWSKYFRGRRLHGDFDIRVEQAEFRDITVVSSADTGPVVTMAAYRSGTRVARSFRPDFVLIRQPPRDGSSDYRSTILGLKYGGVPSINSLHSIYQFQDKPWVFSHLLQLQRRLGRDGFPLIEQTFFPNPRDLVSIRGMMWRTHVLLLRSCFISYSMLHLQHVAIICIPDPVTPPHYRSTRRETFFLSVHLQFQFTKFPSVLKAGHCHGGVATARLENQSALQDAAGLVSGAGNDSHCYCTIEPYIDAKFSVHIQKIGNNYKAFMRKSITGNWKTNQGSAMLEQITLTEKYKSWVDEISELFGGMEVCGLSVVVAKDGREYIISACDSTFALIGDTQEEDRRQIADLVSGRMQNVCRPSMAQTGPGKLPSRSSVSSRAESPTDEGVAPTPPLPAGPRPAPMGGPPPIPERTSPAVGSIGRLSSRSSISEVPEEPSSSGPSTVGGEIANKKRGRTASETSSGSGPGSVPSSAGPGSGFSSSFLGKQFSFAGKGEGVISTQPTQRPSEEPPAIPTTASSAVRPESSVSVSDSRNTDTLTERAGAGYQPVTNYEQQERVNPFDKEPSKSGSAASIHTSSSSSISSSSISSRINRNGNAIQSPPPPAGPPPPPPTNVTAVGSNANSSSGYRNSFSSSLSKDKTSYGNYGSTTSVETITRMDTNTTNIGATATEAGEASGVTAITNISNSDGIVAPTTGTITTSVTTNDWRSAIGMRSASVYSAPAAVTTVLPGDTSGYDSNSIASQGEGLNNPSDLPSYTRPSYSRSESNASKHSDLDVIFGDSKTTPASYGNGKYTRAAGSISDADMIFGGPPSNYKTDRFGASKSMSMTSGGVGSGNGSGSGLGGYKIYDSIQNAAFSDFSDSGSMSSIGSHTKRWSASKEEDDELDLK 986
2 -25.300[R] KOG2350 Zn-finger protein joined to JAZF1 (predicted suppressor)  ali follow..  650......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SKYAAGQELMQRQREEQLKYWLDVGMHKKQEDPKTLKSPQKPAPPADQASTSSASTSGSGSGSSSMQPPKRMPAHLKRGSAASSPGVQSKGTENGTNGSNSSSSNSKNVAKKSADQPLSTLANTRERRSEYGQKRNVSGSRLAATPASKRKLSSKDVEQAADAPEVLTHSDNAVDVGIIDDECGGFGAVGVMNGVASPVANNSEMDTEAEVEAEPTATKAITIHCQQPVTTPVAAAATANERLPGVAPHRRGPRRADRREEELVASAPGYRCRPSMRGADAGAAAAAAAAPTHPHPHRPPPPPPP................................................................................................................... 954
3 -22.700[S] KOG4502 Predicted membrane protein  ali follow..  4.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................STAFLLLLWSSIAGSLPLAPASPDFKADFSKLLKEAHQTDLMPVVEEDELQSLRHNGFQVFYTFHEQLHHLRQKTVGRNSATITEEMARIRNSIEDISEFSLDSNEVDEAINDITVPYGTKMKKSSKFAELSEIHNTDSSNKALPPFAFSEDQQESVDVVEKVEAVPPTTTTTKLTTLPSTTQSTTTRTTTQPSTIVSTRQKYVNVDGDIYVPGKTVISVSSTPIVDRTGTTTPVSIEISTTTLPPMTEIFTTKYSTLSTSYTHTPSPHIFSSSTVRLPIAIPIPTKLPEIMFTTPRPYRGPFITEFTIEPKRSEGRTSLRDRIRSTSQLLNLLGDKIGDQKAAGNRAEPKTGVLTNIYDQGVIKKRNLKTKQWGIAGEDPQGVQTYDGQFSGMAYGATKQRGGGYSMRKRMGKRPWQKRGYKSRRLGDKRPEYMRPSTFVEKRTTDVSVPFGSHWREEWVRGVK 470
4 -19.200[UW] COG5295 Autotransporter adhesin  ali follow..  20.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SETAKSRGKKSGRSKLLISALVAGGMLSSFGALANAGNDNGQGVDYGSGSAGDGWVAIGKGAKANTFMNTSGSSTAVGYDAIAEGQYSSAIGSKTHAIGGASMAFGVSAISEGDRSIALGASSYSLGQYSMALGRYSKALGKLSIAMGDSSKAEGANAIALGNATKATEIMSIALGDTANASKAYSMALGASSVASEENAIAIGAETEAAENATAIGNNAKAKGTNSMAMGFGSLADKVNTIALGNGSQALADNAIAIGQGNKADGVDAIALGNGSQSRGLNTIALGTASNATGDKSLALGSNSSANGINSVALGADSIADLDNTVSVGNSSLKRKIVNVKNGAIKSDSYDAINGSQLYAISDSVAKRLGGGAAVDVDDGTVTAPTYNLKNGSKNNVGAALAVLDENTLQWDQTKGKYSAAHGTSSPTASVITDVADGTISASSKDAVNGSQLKATNDDVEA....... 481
5 -18.900[U] KOG1091 Ypt/Rab-specific GTPase-activating protein GYP6  ali follow..  10  309........................................................................................................................................................................................................................................................................................................................................................VDSSLHSHLVELGVEPQYFLR------W------RVLREFLLQDLLLVW----DEIILAVLGMTVSMIL----RSSLLSTENAT--LLNFPENID---LNKIIQKAKL-------QALVLDTDMLSALSINGVFDQSNFVPARTKSCSTSPRSPLIIAPESYWEKKWRVLHKAEEEENKICLEKQTPPTQKKKRWLNVTKLFRAVIDLSHHKLGIGERKANSSPVTQSLLEDSSEQLNVDCHVTVNKENIHPQETEENIMEFHSADEESIVSGSSPSEESSFVSLDPTSPVRCSTKIENDSVSSAGSNLLPDEDDKSIVSISEENSSVSSDPISPAIDSNYSGKYLDCCTGSENDKDQQTSVNSPLSVSPHRRNEYPVTQSDEDVSTDKSVGITKEYKLLHGIVQWFRKLKRTLSSEETSHRKASDATKTNDVKIKKNQIGCYSESHPQALSSGDSSQNLRKTLKNLGQSMLKHIEAIELVFQQEPCLVPAGLIGNLAKTNLIEKGQVTATTA................................................................................................................................. 826
6 -18.400[R] KOG3253 Predicted alpha/beta hydrolase  ali follow..  13  260.........................................................................................................................................................................................................................................................................................................PIIL-IG----NTGALVACHVSVMEYVTAVVCL-----------DPLLDMKTPV-LFVIGQN-------------SLQCHPEAMEDF----REKIRAENSLVVVGGAD----------------LRISKAKKKSEGLTQSMVDRCIQDEIVDFLTGVLTRAEGHMGSEPRDQDAEKKKKPRDVARRDLAFEVPERGSRPASPAAKLPPSGSEDLSSVSSSPTSSPKTKVTTVTSAQKSSQIGSSQLLKRHVQRTEAVLTHKQAQVPISSEPPEEGEKEDLRVQLKRHHPSSPLPGSKTSKRPKIKVSLISQGDTAGGPCAPSQGSAPEAAGGKPITMTLGQASAGAKELTGLLTTAKSSSSEGGVSASPVPSVVSSSTAPSALHTLQSRLVATSPGSSLPGATSASSLLQGLSFSLQDISSKTSGLPANPSPGPAPQATSVKLPTPMQSLGAITTGTSTIVRTIPVATTLSSLGATPGGKPTAIHQLLTNGGLAKLASSLPGLAQISNQASGLKVPTTITLTLRGQPSRITTLSPMGSGAAPSEESSSQVLPSSSQRLPPA................................................................................................................................ 790
7 -18.100[S] KOG4511 Uncharacterized conserved protein  ali follow..  185..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................HSKDEYDSMQKGSEELEMMAQNSRIQREALEQEIRKEEILLQQALDEGARAQNQNQNQGTSSTQTDGVNAPLRSVAAMMAATFAIDTATSTDDVTYKFLDQSTGTMTSSTGVSVGTLTNTGVSSGTMTSGVDTGTDADGTVGRPKSAKRVGSAVGKRSVSKGTPSEDAKKSSGSSSPDEAEKSKRERPGTSVKKAIGIVAANSEMSSNGTQMDVPVDEEGTKKRPGTTSKKSIATVTASPEMSSKTTQMEPEQDGEGKKRPETSKGANERKYSNAGLEDIVGPKSSPHEEKKSSHPSSRKGSKATDENAPATRPPSRKAAGGSHEPRAKTPNQKNKDERPTTRRSSVDKNAPKRNDSVPRERKSSVSHDESKPPKPIGPLRGNKYDGDVVLGRAESPGIDHGPRRKNLNDVNSHLVDTNRLNSSDVRVRAEQRDKLLQMK 628
8 -17.300[HJ] COG0189 Glutathione synthase/Ribosomal protein S6 modification enzyme (glutaminyl transferase)  ali follow..  10  5.....................................................................RKSGRDYQSPNWRHYRRGFMRIAFFVNGPTFATGLLAMAALNRG---HDVVYLTPGDFTLRSDDTLAVHATVIRKGKYKKPEAFHA-DALMLRNDPSLDQTTRP-FGRLAEQRGVVVLNDPEGLALAQNKLYFQSF----------PEIVRPTTLISRNVEEIRAFADTH--------------------------------------------------------PKGVIVKPLQGSGGKNVFKIGSS---KETNLNQIFEAVSLEGYLIAQAYLPAEGDVRFFMMNGRYAALRRVPAKGDLRSNIHAGTAEAVKVTDEIVELAEMMRPKL-GMFLVGLDIV-----GDKILEVNVFSPGGLSNILELTNVDFSDTIIEAVETKVSMQAASGGALSNRLLATL................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 371
9 -16.600[S] KOG4791 Uncharacterized conserved protein  ali follow..  313........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................APETNTDETPKKAQVSKSLKERLGMSADPNNEDATDKVNKVGEIHVKTLEEMLLERASQKHGESQTKLKTEGPSKTDDSTSGARSSSTIRIKTFSEVLAEEEHRQQEAERQKSKKDTTCIKLKTDSEIKKTVVLPPIVASKGQSEEPAGKTKSMQEVHMKTVEEIKLEKALRVQQSSESSTSSPSQHEATPGARLLLRITKRTWRKEEKKLQEGNEVDFLSRVRMEATEASVETTGVDITKIQVKRCEIMRETRMQKQQEREKSVLTPLQGDVASCNTQVAEKPVLTAVPGITWHLTKQLPTKSSQKVEVETSGIADSLLNVKWSAQTLEKRGEAKPTVNVKQSVVKVVSSPKLAPKRKAVEMHPAVTAAVKPLSSSSVLQEPPAKKAAVDAVVLLDSEDKSVTVPEAENPRDSLVLPPTQSSSDSSPPEVSGPSSSQMSMKTRRLSSASTGKPPLSVEDDEIDL. 792
10 -16.300[O] KOG4275 Predicted E3 ubiquitin ligase  ali follow..  1..............................................................................................................................................................................................................................................................................................................................................................MPCESCGVEFTVFRRKRACFDCK-----------------RYYCANCIA----SRRCKLLKLKPKDLIFYLQSKHISTEGCL---EKEE---LVGLVLTH----------VAQVDRSRGSNASSNSPGRGQANPIDSLKQSCQNFFSNLSDNISDSLASFDSKVTTKPPESRQPEVPTHIFEQPRVSTREIPTYASAVNGGPQHVHVQQQATTTNGGSQSSSSPSTSTQSSNNRDASSSSQAHVAHQEARNEEQEDAQSKSDCECSDEEIMATFSERVSISLKTDTSGRRVNAAAEPSPVDLANVDNGPAGNTAPSPGCSKPGSSSSKADASSQSSFEELGAIGGISDESKANTDTNSSHLDQWQVLEVNRIEAVEETPTTSAADEILEVTLRSRPAVEGDDSEMGESTQALNVNQRPANPSPAFYPAVPQRTKKVTRRRSDGYLNRRYHSSDDESPVAPGGPGLSLGLSTLSEHPEHGLHPHSHRQSRRHLENSQMSEEDIKRELQEFLTYLEQRTKSVDASDADSHAVSPLSVDAISVAAGGRSPDMPITPTIEFSPTQDEDIRWDDDEGIHVYAAPSDFEPTAGIDSRFVNLEDFEDLKDLEGLTVKQLKEVLMLHRVDYKGCCEKQELLD.. 629
11 -15.600[D] COG5072 Serine/threonine kinase of the haspin family  ali follow..  10  13........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SSHTLKSHQVEPPMDFETSFEEFVEDKRFIALEVSDNDDDCDTDLTADTADELESSAILKMRESDASLNVTTGNNTSRKTTSNSKKRWSLLSNHSAVSSSKSKKRWSVLSSSFTSESHKDRESRNVLQQKRKSLQSYSSLDTVASNSSISASSSLKRSSTGLSLRQLFTKIGINDDISQPGIGIPQGKENLPPTMGKKNSSIASTSSENRLRTPLKPLVNHSKRPTSQPQQQQPLYNASLSSRRSSISSTVSSSSSSKWRFWKRNKNQTPALLQPDHHSLKTFPAVNRRDSMTPVEPRNMVKHKTSFSDFHKTIFSSNTYSESSDTISSMEITLKNKASSSSLSLNVLKKRNSQSSLKHKSSHASLQKFKRNKGKSSMIAPSTATNSSNDDSCSYSSKNSTLSHRISLPVPDQVSRDKIQNKLRYSTSLLSLNSKSSLPMNKNDHDETLLRQILLNCDIKRILN.. 476
12 -15.500[O] KOG2231 Predicted E3 ubiquitin ligase  ali follow..  315.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................GRSGQTEQGITSVRTRNDEHNDYQNDLPSITQRHVSIDAGNEEQFPTLRGASTAPSVSLVRPPPPSMRNLSGTSGLARTKENFPALGGGNGGGVTGPTSSSIAARAAQSQHPVAAVFKKPTSAAGSGSRSGPPGNGMLLHVSNRSAAVPKKAATPQVDFPALPGKGNKKNLRNLEEDMLPSGSPVPMANISAKHRSLADDYVSVASPSTFQKLQMVQKEEDEAKARQEALKKSAPKLTAAEFPSLGPSASASSSRTTAPKPSSGSPSLNWSKPANEKKQRELENRKAKVAPAPVLPSPTSKPAPKASNNNVQEQQANKKDKKQKDKKSNQENQPKTAKPKERNNNNEQKTNGAPSTPIRAPPGLKPGGPLKPPPGFVSNVTVNSVAKLPNNLTFTNSLGESYDIVPSPYTYTDPPDTEVRNQKLVDEVMSLLKTPEALN.. 753
13 -15.300[S] KOG3100 Uncharacterized conserved protein  ali follow..  10  4....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TRSARAKASIQAASAESSGQKSFAANGIQAHPESSTGSDARTTDESQTTGKQSLIPRTPKARKSKSRTTGSLPKGTEPSTDGETSEAESNYSVSEHHDTILRVTRRRQILIACSPVSSVRKKPKVTPTKESYTEEIVSEAESHVSGISRIVLPTEKTTGARRSKAKSLTDPSQESHTEAISDAETSSSDISFSGIATRRTRSMQRKLKAQTEKKDSKIVPGNEKQIVGTPVNSEDSDTRQTSHLQARSLSEINKPNFYNNDFDDDFSHRSSENILTVHEQANVESLKETKQNCKDLDEDANGITDEGKEINEKSSQLKNLSELQDTSLQQLVSQRHSTPQNKNAVSVHSNLNSEAVMKSLTQTFATVEVGRWNNNKKSPIKASDLTKFGDCGGSDDEEESTVISVSEDMNSEGNVDFECDTKLYTSAPNTSQGK.... 437
14 -15.200[Y] KOG2992 Nucleolar GTPase/ATPase p130  ali follow..  52.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................TKSPKKIPAIKATAGDSSEDSDSDSESDAAPKKPATAPALTNGKAVKKAASSTSEDSDSEEEKKPAAKATPAKAVGKKAKSSSEDSSSEEEAPKKAAPVKAPPAKAAPAKKVESSSEDSSSEEEPAKPAVKATTTKVAPAKKADSSSEESSSDEETKPAAKPVAKAAPAKKAASSSEESDSDDEPAAKKPAVQPAAKPAPKAAASSSEDSSSEEEVKPAAKSAAKLAPAKKGASSSDDSSSEDEAPKKAATLAKPISKAAPTKKADSSTEDSSSEDDAPKKVAPAKATPAKAIPAKKAASSDDSSSEEEAPKKAAPAKATPAKATPAKKAASSDDSSSEEEAPKKAAAPAKATPAKKAKSSSEDSDSDEEEAPKKPAAKAVAKAASSEDSDSSEDEKPAKAAPKALAKSAKAASSDSDDSSDEETPAVKPAVKKTAAPAKKADSSSDESDSGEESGEVKPNSATNGNEKTAQKRKFSGGDQDEATPNKKYNNFVKSGEQQKNDFTSTPNNTFSRNHNMNNSGGGSGR.... 578
15 -14.800[U] KOG2724 Nuclear pore complex component NPAP60L/NUP50  ali follow..  65................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KVDDDVAADMTVPRRTENSSESSGETVAPRKIAKAVRKNGTPKNPLNSTVFAASSPAATVASVPKFGDISVITKETPAPLAKTAEPLVAPAAPATARKRAIRGGGPLGGAESVVFKSGEDGQAATSSVKIPATTIKFPEPTKDFWTKKSDAPAAPSNSGSLFAFLGKELFSIKKNPPIYQNFSGDKPKETPKFSGFSFGKKPAEPSEEPKAADSTPKLTFGSPKEADLPKPASSLFGASPSKPLVFGGSSADSTTSAPKPFSALSTAASLFGSSSASTTTTATQPLSFGSSSTGGSSLFSGFAGLAQKAMENQNQAKPEGSGEDDEGEYVPPKVETVENQEP.... 406
16 -14.700[S] KOG2465 Uncharacterized conserved protein  ali follow..  277...........................................................................................................................................................................................................................................................................................................................................................................................................................................................AEMAVTKPKG---SGVETPTSEPGFCATDMWDEWEEENDDYCTYRHQRRLSDPSANLNNFSRYGWRTKNSNNQDMVGSGTSPSVGAKARSENEGLDSLASEVSEIEAGDLRDDQQRPAFSASAAKLHPNPNCETHKLATGDQEKLTQESPRESTSSAPAEVAVPAVTPPPLSAAVEVTVSGDVSVTGHSSTTGCNCFGGKKCKKRWASAKNTDTPEMSEVYCPSCEDPSNESPACLAKMPDKRPTRLKPKSSILSVESELLVGKRSSFRLPSEIKRKQQGGSITRSASLSAADRRTSLPVATKRIIPPRLRTAKAKDLEKDKEKEKDKNKENDKKSSNQKVNGSATNFLAKMSPKRLKAGKEKDKDKDGNKEKEKDKFKAMDAAKKKAVNNNNPKPDISKSEEYEIADDATSLNGSESEPVGAAKMVILSESDSKLMISVRGREELPVVDSPKTPPKRFEKCVSLPVEPESHLLQPDENNENEQSDITNVISPTELTPMLDVANGNGEANSATLPRTAKQAHVSKMLHLVPKRRTPDGT.... 812
17 -14.200[B] KOG2748 Uncharacterized conserved protein, contains chromo domain  ali follow..  10  1.......................................................................................................................................................................................................................................................................................................................................MELPAVGEHVF-AVESIEKK----RIRK-GREY--LVK------WRG------------SPKYNTW----------------------EPEENILD-------LLIAFQNRERQ-------QLMGYRKRGPKPKPLVVQVPTFARRSNVLTGLQDSSTDNRAKLDLGAQGKGQGHQYELNSKKHHQYQPHSKEGKPRPPGKSGKYYYQLNSKKHHPYQPDPKMYDLQYQGGHKEAPSPTCPDLGAKSHPPDKWAQGAGAKGYLGAVKPLAGAAGAPGKGSEKGPPNGMMPAPKEAVTGNGIGGKMKIVKNKNKNGRIVIVMSKYMENGMQAVKIKSGEVAEGEARSPSHKKRAADERHPPADRTFKKAAGAEEKKVEAPPKRREEEVSGVSDPQPQDAGSRKLSPTKEAFGEQPLQLTTKPDLLAWDPARNTHPPSHHPHPHPHHHHHHHHHHHHAVGLNLSHVRKRCLSETHGEREPCKKRLTARSISTPTCLGGSPAAERPADLPPAAALRQPEVILLDSDLDEPIDLRSVKSRSEAGEPPSSLQVKPETPASAAVAVAAAAAPTTTAEKPPAEAQDEPAE............................................................................ 526
18 -14.100[R] COG5236 Uncharacterized conserved protein, contains RING Zn-finger  ali follow..  323..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................STFISAPSRVIRERDDYDLPSISSLPGSSSGSRTDVRSASSPEESRLRLAERAKYYLENSKEDFNKFSSYNEDYSKGRLSAEKLLESYKLLFTKPNADVYLLIHNLAETFPKNSSKYNNLNAIYEQREQTLARQTSLPSLSSDSSLSMSIGRGHWGGTNDGGSAGAALGVRNIKNLPTLKSPSASYDPFATTVKKNTLRPVQNIKRTTPQSVSYRTSTNTVAFSPTYLESKKGSSSTSLNNSKDKLKSLNLPQLPPPKPKVQIPGLNRPQIADPKQWG-----KKSSTQDTNVHDNLRELNTTSGGNKKKGKQKQLL... 634
19 -13.500[R] KOG4227 WD40 repeat protein  ali follow..  529............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................NESDSEENVCEVELDTDLFPRPRSPSPEDESSSSSSSSSSEDEEELNERRASTWQRNAMRRRQKTTREDKPSAPIKPTNTYIGEDNYDYPQIKVDDLSSSPTSSPERSTSTLEIQPSRASPTSDIESVERKIYKAYKWLRYSYISYSNNKDGETSLVTGEADEGRAGTSHKDNPAPSSSKEACLNIAMAQRNQDLPPEGCSKDTFKEETPRTPSNGPGHEHSSHAWAEVPEGTSQDTGNSGSVEHPFETKKLNGKALSSRPPSPPVPKASGSTLNSGSGNCPRTQSDDSEERSLETICANHNNGRLHPRPPHPHNNGQNLGELEVVAYSSPGHSDTDRDNSSLTGTLL----------DCCGSEMACETPNAGTREDPTDTPATDSSRAVHGHSGLK-----ELEDTDSENSSS-----------EKKLK 941
20 -13.500[R] KOG3612 PHD Zn-finger protein  ali follow..  44..........................................................................................................................................................................................................................................................................................................................IFHPMDLCTLEKNA-----KKKMYGCTEAFLA---D--AKWILHNCIIY-----GNHKLTQIAKVVMNEIEVCPEFPFWPAKAARFFGQHDRAWVPI-------NNCYLMSKEIPFSVKKTKSIFNSAMQEMEVYVENIRRKFGVFNYSPFRTPYTPNSQYQMLLDPTNPSAGTAKVDKQEKVKLNFDMTASPKILMSKPVLSGGTGRRISLSDMPRSPMSTNSSVHTGSDVEQDAEKKATSSHFSASEESMDFLDKSTASPASTKTGQAGSLSGSPKPFSPQLSAPITTKTDKTSTTGSILNLNLDRSKAEMDLKELSESVQQQSTPVPLISPKRQIRSRFQLNLDKTIESCKAQLGINEISEDVYTAVEHSDSEDSEKSDSSDSEYISDDEQKSKNEPEDTEDKEGCQMDKEPSAVKKKPKPTNPVEIKEELKSTSPASEKADPGAVKDKASPEPEKDFSEKAKPSPHPIKDKLKGKDETDSPTVHLGLDSDSESELVIDLGEDHSGREGRKNKKEPKEPSPKQDVVGKTPPSTTVGSHSPPETPVLTRSSAQTSAAGATATTSTSSTVTVTAPAPAATGSPVKKQRPLLPKETAPAVQRVVWNSSTVQQKEITQSPSTSTITLVTSTQSSALVTSSGSMSTLVSSVNADLPIATASADVAADIAKYTSK 741
21 -13.100[R] KOG4377 Zn-finger protein  ali follow..  2..............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PKAQHSPQAIFTSFKLERSEYSGPGARLPGGSSSTVATAEDRLSLADHDGSATDLTPSRYRKRGRVWAPTSSLEQPSKRIVNQPTHFGARSETESRSSRHESLAQPTLQPSEPLETNSSTNLSSTILDKVSVVRAAGTFYPENANSAAQGETPEVVSSRYNSRQESNDLEVDQPEDLSMRPSLPEATATPAVVGPALNMNLLQFKQLIDLYQRQVLLPSFLAAASQPLALPGSAAGPGVSGPLLDMRILLENAAQQKLMLLNAAASATASAVAATTINSGQRTAAKRNRDHDIPSG.................................................................................... 297
22 -13.100[R] KOG2295 C2H2 Zn-finger protein  ali follow..  174........................................................................................................................................................................................................................................................................................................................................................VMRKYT--------EYKTFKRQQLNEFFVAHKDEEWFKN--LQRRTDVFMELLEN--GTIGSVKVDS----SQADALIRVLDTCVIKLEGGTDEDLKVLDE----------KPKDPVVYERKAEQMQSVKEVEKTINSPKEEMSEADPVSTQRKPVRPVNSDGENWDDDDAENSAPKKELAEDSKDSDSKPEDKQLNKKKTKKRKRNSSDDDSSSSESSSSSDEEKLKEKYDVEDGLRAEQKTEAEKDRQEATKAKQGPQSPKLDEDEGNENTEPKGLDSKINTYEEIDNTLKSPEISSNPIKNTDNGDGSKVEEDGEKPSVGKDKVVETETIDLDKVKDGQPRALHRTSS................................................................................................................................................................................................................................................................................................... 516
23 -13.000[T] KOG2381 Phosphatidylinositol 4-kinase  ali follow..  2..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SGARDQTDPPLLQLEDEVDLIGDFAKDQPPPRNQLSPLLNGFESTSNQLTTKVEINTVGMGKRKTRRRGKKAREPMLLSVDDEDDEEEAQEERNHTNGLPPGEESAGGDAVIQKPQLDNLVMHYDDQIDDEDGEEAVLLKRSSNPRNQRLKGSAEDSIDSSSQQPPIICHIAPAKVASSALTSPLKTTSHTALARHPHDEADDICLVPEIDFEGMSTDAGSDNRESQPLLGGGNASHGSRISELLGGLGRGHDHVEFVSNTFGAKYQEPSEPRDDEQPTTSKDALESSSSVPSASAAYACICCEHKCPLEKDFLESQSDKEDPPFLVNSPSMARDSKDTVTVQIAAPRCNC. 353
24 -12.800[S] KOG4615 Uncharacterized conserved protein  ali follow..  1................................................................................................................................................................................................................................................................................................................................................................MVVFGQDFQAKLLPEI-----TVAAAGLVHRVCATT-----------LFSLVGLYFLNRIKSKPQNNDTLELDD-------SQPVKDKERFAAFMMRK----------LAENKPAQNDNLFGNFKLDFDLDFEVPLIKKSQAKPKSKLPEVQPLGELVSK---------NSAATEKVNEPPVDQAPNENVPPRRSPTLSPNNRRSMRRSGNVPGSDKLRRHAIRRRSRSCGRQLLPEFEETVNLTRSISSPVNFLPEISSTPCTEKQKEEVAKNTTRVETDKPAEKPMELSQEPEPENPLQTKVTSPARNPILAAEIEQICKERQSSFHKNVLQLDYSGRAPYSRPPTPSSPSVAGLRRTYTMEKGPAPGQLLLSPSHRYDTPSKMPVVKAKRFNQELMVPDTPERQSHDPAWQSEPQPEFVVPETQPQDLGELVQTLSRSAISPIVVINTSNSNRSVRRDAVAMKSVPTSPVTALSSPPIAPSPRRSAAASPQKSIAQLPRVEENMDAIMTDDESDEHPSTVPLNLAPSGGNTTRQRRLRSSNRARATIESQESSMRLLNLHKSVNAKKSKPRKTAIPLNKAPSAPINGEQFARELTRMSNYEILDLRKRNSLNEIYPLNGHRNHRSEKLILE 624
25 -12.800[S] COG1652 Uncharacterized protein containing LysM domain  ali follow..  25...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................VLPRISNDGKPIGDAINEAGNAVKNSVEMGADKAGDILSDAAEETASIADKVGRRAASATQSIKDMASLFADNKVPSDADFAAARKKVEASLKELTNIDIPESLDETTSRLITTARAAAERTTAFLRGLPDNAAAAAAQVRRLAGVFAGTDDGAPQAANPTAAPADAAQASSGTPTFDVLRVEPDGSAVIAGKAQPGAKLEILSNGKVIAQTTIDGTGDFAAVFDNPLPPGDHELVLRSTDANGKATQSEEVATVSVPQSKSGELLAMVSKPGKASRVLAMPEAAPPALQPQQATPSQPSAATSETTANNTPVPSSGTAAPTAAGSTAVAPLTSSVQVTAVEFEGSKIFVAGSAPGGSTVRALVDDKEIGKSTTEASGHFVIEGDVDLAVGSHIITVEELNADGTAKVRVRVPFERPQTDQATVAMQAPSASSSAN....... 460
26 -12.700[TZ] KOG4035 Coeffector of mDia Rho GTPase, regulates actin polymerization and cell adhesion turnover  ali follow..  1.......................................................................................................................................................................................................................................................................................................................................................MLKALYDISFDE-GEYFILYQTSARQRNW--------------------W--QVVSMKGNIGFVPSNYVMKKVEHDFLISFLNSSIESLEKCTDHEINGIMS---DELLDRLREKKHTMERLYAESSERDGDSSLSYSHSYSDKGSHRHSHPHPTQSQTQLHSQHRQHSPPPSGGSVGSQRLDMSKKSMSSPAVGSSCGLPQNQGMIESPSMGSMQFQGSSCTIQTPQQQQPLPAPPAPAPSPSAASATPTAASTSKAATGGDVAQDNSITSEPSETTTTTTTTSEDVVTTYKETSQMSTSQQHKPQNGSTASASISASASASALRSNGGNGKANGSATALHQELQQEEADSAPDKSDDASAVQSDDGCPANGDSADNSQALDSIDSPSHRQRGLSLGRIEEGATGGGQLKVESSDVYQIVDALRRNTNLSFDLSCEA............................................................................................................................................................................................................. 422
27 -12.500[R] KOG2893 Zn finger protein  ali follow..  11  1.....................................................................................................................................................................................................................................................................................................................MGRKKKKQLKPW----------------YCNRD-FDDEKILIQHQK-AKHFKCHI--------KLYTGPGLA--IHCMQVHKETIDAVPNAIPGRTDIELE-IYGMEG---------------------------------------PEKDMDERRRLLEQKTQESQKKKQQDDSDEYDDDDSAASTSFQPQPVQPQQGYIPPMAQPGLPPVPGAPGMPPGIPPLMPGVPPLMPGMPPVMPGMPPGMMPMGGMMPPGPGIPPLMPGMPPGMPPP------------VPRPGIPPMTQAQAVSAPGILNRPPAPTATVPAPQPPVTKPLFPSAGQMGTPVTSSSTASSNSESLSASSKALFPSTAQAQAAVQGPVGTDFKPLNSTPATTTEPPKPTFPAYTQSTASTTSTTNSTAAKPAASITSKPATLTTTSATSKLIHPDEDISLEERRAQLPKYQRNLPRPGQAPIGNPPVGPIGGMMPPQPGIPQQQGMRPPMPPHGQYGGHHQGMPGYLPGAMPPYGQGPPMVPPYQGGPPRPPMGMRPPVMSQG................................................................................................................................ 475
28 -12.300[R] KOG4307 RNA binding protein RBM12/SWAN  ali follow..  7............................................................................................................................................................................................................................................................................................................................................................................................LKNLP----MTAGASDVRTFFTGLKI-AVHIIGGDEGEVFVGSDDDARLAMTKDRLMIHGAEV-RLFLSSKSEQ--------------------NSVIAARKNNTYTSPVYKEYVPPVPSQPTPAQEQNWNSQTAGNPYAAKAGYEASYPPQNSNATRTSFNNQNSYSNRQEISQNHQENSVKLKDPFGGDYGGYKFQQQPPPQINRYGSGPPPSKPADLSNTRSLPPVNNPPPPHPIPQFPPEKQFGNKLGNNNDVSSRENHIQGSGNERVQGGDSWRDTSFNQPPRNDFKGNYNNAYSSNKYKNNYKAPEFNNDFNGGNKFNQFPPRNAQSTDLSENRAAPPQTGRKTLMPTPQAPFQNAPAPFTNGPSDDVNRPFQTGPPGNLGRNGPPPFQAGVPPPVIQNNMGRPIAPPAAMVRPPPQNFPGGAGGALPVFQAPVMTPIVPPVNKPMGAAAVEKFYIELTRLPTDLLRPAALEAFIHPTAPLTLSSVKTVFGPGGIHMHTIIRLDSIADYATMMRRNGEQGIKIQQSDKKSFDTAIDGIPIPSVSMVPSKEQRSHEDDDKKSRRSRWENTSPIRSPRRSPLRRDNRDRSRSRSPPRR.... 587
29 -11.900[S] KOG4483 Uncharacterized conserved protein  ali follow..  2...................................................................................................................................................................................................................................................................................................................TGYG-------------------------------------YNSNVQQVQQ-------QGVNEEWTHTTGQSQYYH----------------------------------------------------TDSGATGLSMLYGSGWYQPPNYNNYPAAPEHNVVDQQRSPPDAMDNTRALAYQNQMFMMQAANLAPPPQPRVSFSDEELYQALNMSPLPPTATFHALHQQQQQQQQHQSMKQQHAMHLQQQPQTDYLSSEVCYPSTSSYEPSGYNESGYCPQNSTILPDDPQNYQHGNDGDDEESFGEPERYEPMSPTFSIHSFAPTTSTNTAEAEDLEVCIFFPAIFFISKLLLELINNHKPTPRYQLSDDIDIFLHTGTTDDTEYNDDSDSRPTTTFSHRSTKAPTPPASRPAYAQKFTAAAQNLKPEQQQPTTSDITSPISKTSPLFLQTTGQDPAGFTPLLTPNSDALLQKKLSEVVHNPPQRAIGLSAFPAFPQQPPHLTRFQENQRYEGNFVEYQPPPPQQHQQQQPQAPEGFYPPISLNTRYDYDSDRDILPLLLDTFQPLPAPPQIPPVTVSVPVSVPELLTSTKKPSQPAKVPAAPIKAPRLSDQELESESQKLALDVISNLFSNKKEIIDRAAVLSAPKKPVARNLFCNDPESLEKAKSSEPLTMSVLD.. 591
30 -11.900[S] COG1511 Predicted membrane protein  ali follow..  41.....................................................................................................................................................................................................................................................................................................................................................DPYGTVD-QLPVVVVNQD-----KGATYEGEKLQIGDDLVKELKDNNNFD-WSNDLDQSLKDL----------LNQKYYLVDFSKNASTVLDKNPKAGSNYVGATIGEKAIDKLKASVSKEVTEQYTKVIFDNFKDIAKGLSDASSGAKKIDDGTKDAKNGSAQLKENLAKLKESTATISDKTAQLADGAAQVTSGIQSLDSSLGKFQDSSNQIYDKSSQLAAGSGELTSKMNELLANVQKGTPNLTNGLDQLNSKVQEGSEKAAKAEKIINALDLTKLETAVNNLEKSETAMKEFKKQLTDFENSLKNRDQAFKNVINSSDFLTAEQKSQLINSVEKKLPQVDAPDFDQILSQLPTADQLPDIATIKSSLEDVKAQVAQVKAMPEATSKLYNGAKTIQDAIDRLTEGADKIYNGSQKLTDGQTKLTAGIGEYNKQFAKAKAGSEQLVTGSSQVSGGLFKLLDGSKQVQSGSSKLADGSASLDTGLGKLLDGTGELSSKLKDAADQTGDIDADDQTYGMFADPVKTKDDAIHSVPNYGTGLTP...................................................................................................... 585
31 -11.800[U] KOG4573 Phosphoprotein involved in cytoplasm to vacuole targeting and autophagy  ali follow..  294..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DFEDGKQYDQPPPSFATRLAKQSDPNSLLQSEIQHLASIESITAQAAPLVTIHPFKSPSLSASPGSNFDNMSISPKVAVNRYIHRGPSATSLNKFSMISDAASKSRAKLPPLTSGSLKLNTLDISNTPNLRRFSSSFGPRERKESFSSRNRLPLVNHPIRSIFKHNVSENPITDHSEHAVYDSEFASKDDLSGFIQLLDSHAHHLNASEGSKSSGSFPGKVQTLTSGISPVAHPHNSLGSSNEIFDIDTYNHSIDNSGSRFTEAVKHNLGNSSHSIMRHHTLGTLRSRPSFSEKSTFPAPLTSISQASTFQGDNRSPSTVIPHTQTEVPSANDTSKQLASLHDMRKSQSPICARSATSAGLPRFEYHTSLSKSLEHSSTPASLQATKTPSPSLEPGIPQEYKKHFDNLSEERRQCLTPSTPTYEYYNEHNPNYDDDLDMT 740
32 -11.800[K] KOG2821 RNA polymerase II transcription elongation factor Elongin/SIII, subunit elongin A  ali follow..  2.......................................................................................................................................................................................................................................................................................................................................................................................AAESALQVVE---KLQARLAANPD-LSTLPI-TVDILAETGGK----TVNS--------RKHEHVGSFARDLVAQWKKLVPVERNAEPDEQDFEKSNSRKRPRDALQKEEEMEGDYQETWKATGSRSYSPDHRQKKHRKLSELERPHKVSHGHERRDERKRCHRMSPTYSSDPESSDYGHVQSPPSCTSPHQMYVDHYRSLEEDQEPIVSHQKPGKGHSNAFQDRLGASQERHLGEPHGKGVVSQNKEHKSSHKDKRPVDAKSDEKASVVSREKSHKALSKEENRRPPSGDNAREKPPSSGVKKEKDREGSSLKKKCLPPSEAASDNHLKKPKHRDPEKAKLDKSKQGLDSFDTGKGAGDLLPKVKEKGSNNLKTPEGKVKTNLDRKSLGSLPKVEETDMEDEFEQPTMSFESYLSYDQPRKKKKKIVKTSATALGDKGLKKNDSKSTGKNLDSVQKLPKVNKTKSEKPAGADLAKLRKVPDVLPVLPDLPLPAIQANYRPLPSLELISSFQPKRKAFSSPQEEEEAGFTGRRMNSKMQVYSGSKCA................................................................ 543
33 -11.600[Z] KOG3756 Pinin (desmosome-associated protein)  ali follow..  303.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................QKAEQEEGKVAQREEELEETGNQHNDVEIEEAGEEEEKEIAIVHSDAEKEQEEEEQKQEMEVKMEEETEVRESEKQQDSQPEEVMDVLEMVENVKHVIADQEVMETNRVESVEPSENEASKELEPEMEFEIEPDKECKTLSPGKENVSALDMEKESEEKEEKESEPQPEPVAQPQPQSQPQLQLQSQSQPVLQSQPPSQPEDLSLAVLQPTPQVTQEQGHLLPERKDFPVESVKLTEVPVEPVLTVHPESKSKTKTRSRSRGRARNKTSKSRSRSSSSSSSSSSSTSSSSGSSSSSGSSSSRSSSSSSSSTSGSSSRDSSSSTSSSSESRSRSRGRGHNRDRKHRRSVDRKRRDTSGLERSHKSSKGGSSRDTKGSKDKNSRSDRKRSISESSRSGKRSSRSERDRKSDRKDKR................................................................................................................... 716
34 -11.600[U] COG3846 Type IV secretory pathway, TrbL components  ali follow..  10  272.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PPMFASIVGGGGATAGIGNFGAGAAIAAAATGAAVAATAGSALAAGLSSAGGGVSALKAAFQSAQQNMASGGGSGSGSGSGGNSAGVSSGGSSSFMSAMGTTGRFAADMGTSLAKGVGQVAKDKAGSVIASAKERVADTTGGKVASAIRNSMDAASGQNDFKGDSLAGAAQRGSETAMNDEVAAFVNKGKQHE.. 464
35 -11.500[R] KOG0041 Predicted Ca2+-binding protein, EF-Hand protein superfamily  ali follow..  46....................................................................................................................................................................................................................................................................................................................................................................................................................................................PSVDTSIDDLIFKALEKKEENNNNNNNNNSNSTTTTPLEIKTERNQQHEHTTIDPRSPPPKRSILELLEQERLENELQQQSAPVPKTPVMVITKGAFPRSASPRRQQFVRENEDGNELEKRLAAQRMKKYTEEMESLVQKQVDVLDQIMSSPPPPPTSPPQLPPTPPARITSVRSDESIEEEERRRKESEETASFEELEAEIMRISRSPVP--PPVLSIPPPPPPNIPLPTIPQEVQSPPSPRPTSVPPPIPSPGPSEDVNMDELIESFSDSVIFNNSMSPPPPLPPLRESSLETLEVTPEDPVTESKVEASPTPLPKATESLNESSIKALEGLEVKALEAQEASDDRPSAPTPIRDSSLPPPPPPKPETPLAIRRAGPIPTPQLLEMIHQEDCSIRPSSPTSVSHGSRPQSPAVPKKPSVTVSPLGLLCDPNLSIEKPEEMKTEDTKPVETAPAPVDEAELNDALDRRNKINEATCLTKIFPSLVSKYFQNCSFDFLNDKRSGENVPLKMNKKISLYAEFSEFSRKQIQYFSGIFKKYDEDQDSYIDLK 596
36 -11.500[U] KOG1955 Ral-GTPase effector RALBP1  ali follow..  12  228........................................................................................................................................................................................................................................................................................................................................KITDEQRQYY--VNQFIQPDLNGFIP--GSAAKEFFT-------KSKLPILELSHI--------W-----------ELSDFD----KDGAEFCAAFH--------------------LVVARKNGYDLPEKLPES------------PKLIDLEDSADVGDQPGEVGYSGSPAEAPPSKSPSMPSLNQTWPELNQSSEQWETFSERSSSSQTLTQFDSNIAPADPDTAIVHPVPIRMTPSKIHMQEMELKRTGSDHTNPTSPLLVKPSDLLEENKINSSVKFASGNTVADGYSSSDSFTSDPEQIGSNVTRQRSHSGTSPDNTAPPPPPPRPQPSHSRSSSLDMNRTFTVTTGQQQAGVVAHPPAVPPRPQPSQAPGPAVHRPVDADGLITHTSTSPQQIPEQPNFVDFSQFEVFAASNVNDEQDDEAEKHPEVLPAEKASDPASSLRVAKTDSKTEEKTAASAPANVSKGTTPLAPPPKPVRRRLKSEDELRPEVDEHTQKTGVLAAVLASQPSIPRSVGKDKKAIQASIRRNKETNT....................................................................................................................... 708
37 -11.400[K] COG5641 GATA Zn-finger-containing transcription factor  ali follow..  2................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ASQATTLRGYNIRKRDNVFEPKSSENLNSLNQSEEEGHIGRWPPLGYEAVSAEQKSAVQLRESQAGASISNNMNFKANDKSFSTSTAGRMSPDTNSLHHILPKNQVKNNGQTMDANCNNNVSNDANVPVCKNCLTSTTPLWRRDEHGAMLCNA-KSRNRKSNTNHAHNLDNFRNQTLIAELKGDCNIESSGRKANRVTSEDKKKKSSQLLMGTSSTAKISKKPKTESKERSDSHLSATKLEVLMSGDCSRPNLKPKLPKQDTAIYQEKLLTFPSYTDVKEYSNSAHQSAFIKERSQFNAASFPLNASHSVTSKTGADSPQLPHLSMLLGSLSSTSISNNGSEIVSNCNNGIASTAATLAPTSSRTTDSNPSEVPNQIRSTMSSPDIISAKRNDPAPLSFHMASINDMLETRDRAISNVKTETTPPHFIPFLQSSKAPCISKANSQSISNSVSSSDVSGRKFENHPAKDLGDQLS---TKLHKEEEIIKLK 508
38 -11.400[KB] KOG4161 Methyl-CpG binding transcription regulators  ali follow..  128..................................................................................................................................................................................................................................................................................................................................................................TIGARLEA---LSVEGNW-----PARIVEVNETESFQEWMAIKSERL-DEKCMA------SGPRKFIRKLLNDTYEVL-----DDVKNVRAVHMNKMPKQLPPVQVAEEGASKSPTPVGTPVSSAPVAPKRASTGSLGGSSGSSGSKKSKCAPQRRDWPLLDMASLDIASLGLPEIPHDGEWTCHWVNDQPIGTEGFLIVGESPSGKRFRSKSDLKLFLESQNLVYNPDVYDFSIHRRRAKDINAYVYTHGYNPQPPPKPRPMDVSMNSTLDQSITSQHSLPSTPMPVKESQYMEAPVASLMPPAELMSPQTQPADETKPKIEAEILEASEGGTSQLMLADPHVVENGFAFIGGLKVKIQDNLYVCPREDCAKTYRKEDKEFAEHVSHCPKMQELAVKRTHPSSIDQVEAVPKNQIPNQQFFAKMHQQDLQQSRSFKRQSVSATATSSTPSDITPTKALLSPKMEPPSVSPTVESGIKQEDVSLDAGPTQSFNPSLSRSCKRARLSPSKRPSGSRKSNRQRSQRRPILSDNPAGHGLTEQDVEETRQSFNTPTPDTRIDSKKRRSGAATTPISSIDSPAMGDSVST---------PSSNDQTDINAALAPPPAETLSKAPQYIKENGEL-IR 820
39 -11.400[K] KOG0323 TFIIF-interacting CTD phosphatases, including NLI-interacting factor  ali follow..  255.................................................................................................................................................................................................................................................................................................................................................LVKLRPAWRKRFEVYVCTMAE--RDYALE--------------MWRL---------LDPEAHLISLKELRDRIVCVKPDAKKSLLSV-HPKMAMV-----DDRMKVPRVHVVSAYLPYYAPQAEACALVVPHLCVARNVACNVRGYFFKEFDESLMSSISLVYYEDDVENLPPSPDVSNYVVIEDPGFASNGNINAPPINEGMCGGEVERRLNQAAAADHSTLPATSNAEQKPETPKPQIAVIPNNASTATAAALLPSHKPSLLGAPRRDGFTFSDGGRPLMMRPGVDIRNQNFNQPPILAKIPMQPPSSSMHSPGGWLVDDENRPSFPGRPSGLYPSQFPHGTPGSAPVGPFAHPSHLRSEEVAMDDDLKRQNPSRQTTEGGISQNHLVSNGREHHTDGGKSNGGQSHLFVSALQEIGRRCGSKVEFRTVISTNKELQFSVEVLFTGEKIGIGMAKT---------------KDAHQQAAENALRSLAEKYVAHVAPLARETEKGPENDNGFLWESSEDVSNKGLEEEAPKENISEL............................................................................................................... 771
40 -11.300[K] KOG0709 CREB/ATF family transcription factor  ali follow..  10  278..........................................................................................................................................................................................................................................................................................................................................................TKAEERDLK--------IRRKIR-----NKRSAQTSR-----RKQDYIE-------QLE---------------VSESTKENQALKQQ-SSENQSVISQL--KKLQAQLGQNAKRTTQAGRQDNQKVLECIEEACQPSATSMNSANSAQRAIAGVTAPSVVIPSGGPVMVSTNANRQMNRNAVLNHHNNSKYPASGNQNHHPIALEDLNHPPPTLQPKQSYQQQHQPSMYRRSDETIAMAMAKIGARKGSSTSSSSASSVASSTSTSSATSPIYRTSRTLGAFEDQCDASSDDSNCANMPSLVPMKMSAQPPKRKIVTMNGQPRVTYRAVPASSVNVEQAQYYKVPQQKVQYVTMDRPIKYEV--NDYIKMEEESTIRLPNSWSTAGPRLHPQVNASSRTVRPLTVATPVHYNGPSAKKIKTQ......................................................................................................................................................................................................................... 686
41 -11.300[OT] KOG0505 Myosin phosphatase, regulatory subunit  ali follow..  420..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SSGLFNKPEEPKDESPSSWRLGLRKTGSHNMLSEVANSREPIRDRGSSIYRSSSSPRISALLDNKDKERENKSYISSLAPRKLNSTSDIEEKENRESAVNLVRSGSYTRQLWRDEAKGNEIPQTIAPSTYVSTYLKRTPHKSQADTTAEKTADNVSSSTPLCVITNRPLPSTANGVTATPVLSITGTDSSVEAREKRRSYLTPVRDEEAESLRKARSRQARQTRRSTQGVTLTDLQEAERTFSRSRAERQAQEQPREKPTDTEGLEGSPEKHEPSAVPATEAGEGQQPWGRSLDEEPICHRLRCPAQPDKPTTPASPSTSRPSLYTSSHLLWTNRFSVPDSESSETTTNTTTAKEMDKNENEEADLDEQSSKRLSIRERRRPKERRRGTGINFWTKDEDETDGSEEVKETWHERLSRLESGGSNPTTSDSYGDRASARARREAREARLATLTSRVEEDSNRDYK 883
42 -11.300[U] KOG0866 Ran-binding protein RANBP3  ali follow..  2............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ADLANEEKPAIAPPVFVFQKDKGQKRSAGGSSPEGGEDSDREDGNYCPPVKRERTSSLTQFPPSQSEERSSGFRLKPPTLIHGQAPSAGLPSQKPKEQQRSVLRPAVLQAPQPKALSQTVPSSGTNGVSLPADCTGAVPAASPDTAAWRSPSEAADEVCALEEKEPQKNESSNASEEEACEKKDPATQQAFVFGQNLRDRVKLINESVDEADMENAGHPSADTPTATNYFLQYISSSLENSTNSADASSNKFVFGQNMSERVLSPPKLNEVSSDANRENAAAESGSESPFQEATPEKESLAESAAAYTKATARKCLLEKVEVITGEEAES.... 331
43 -11.200[A] KOG2548 SWAP mRNA splicing regulator  ali follow..  10  20.......................................................................................................................................................................................................................................................................................................................RKRAERRQYFADPTQFLQLHGRRSKIYLDPA-LID-RFDVRLDHIPPNYERY-RILAQNDFLNVSEDKFLHQLYLEEQFGANAQLEAE----MDV--IGKLDTSQGRNYGMKSNDFFSHLTKDADEADALRIAREEEQEKMLLSGRKSRRSPPSYAAKEDKDKKGGGKGGEKEKEEDSESRSPSPAEAGPEKITYITSFGGEDEMQPHSKITISLTKPGLTLGESCINASSGAAIAAAAASSVSYAQKVKDNLDKLKVMNESSKRNRRRSRSHSRSRSRSATVSRSRSGSRRSGSRRRSRRSRSYHRRSRTRSRRRRRYYSRSRSRSRSRSRSLSRSRSRSRSRSRSGSWKRYKARSPSYKRSRKRYSYSSRSSSGSSYRRRSRSRSPSNRRSRVKKKTTPPPVATVGGYCLNTTTTTTTSTVTAVKMFQQQQQQPPAKATPPMISYPIPARMLNVNQALTATAPVAVQPQVVEPPPPPLKRYYGRKRGNDTSSSSSSGAENSEGSDNEEQQQPQLGKRAEDSDDMELDTASERSHALQPTMSSSSSTGNQTGKYSSATETGSGHPSSGGGGRPNLRERLKRKMQNLLNRQYKADKRAEIEKTERERLQQQEREDEMRELALKLRRRRRELRHKYGTPSSGKLSDSDAESVASESQLAKSSTRRSRSRSES.... 816
44 -11.200[K] KOG2150 CCR4-NOT transcriptional regulation complex, NOT5 subunit  ali follow..  10  1.....................................................................................................................................................................................................................................................................................................................MAHRKLQQEVDFNSYYERHESCTNNPSQKDKLE---DLKREVKLQRLREQIKS---------WQSS--PDIKDKDSLLDYRRS-VEIAMEKYKAVE---------KASKEKAYSNISLKKSETLDPQERERRDISEYLSQMIDELERQYDSLQVEIDKLLLLNKKKKTSSTTNDEKKEQYKRFQARYR------------ESNQDPDFVEDETIYDGLNLQSNEAIAHEVAQYFASQNAEDNNTSDANESLQDISKLSKKEQRKLEREAKKAAKLAAKNATGAAIPVAGPSSTPSPVIPVADASKETERSPSSSPIHNATKPEEAVKTSIKSPRSSADNLLPSLQKSPSSATPETPTNVHTHIHQTPNGITGATTLKPATLPAKPAGELKWAVAASQAVEKDRKVTSASSTISNTSTKTPTTAAATTTSSNANSRIGSALNTPKLSTSSLSLQPDNTGASSSAATAAAVLAAGAAAVHQNNQAFYRNMSSSHHPLVSLATNPKSEHEVATTVNQNGPENTTKKVMEQKEEESPEERNKLQVPTFGVFDDDFESDRDSETEPEEEEQPSTPKYLSLEQREAKTNEIKKEFVSDFETLLLPSGVQEFIMSSELYNSQIES........................................................... 630
45 -11.200[S] KOG2995 FOG: SH3 domain  ali follow..  1......................................................................................................................................................................................................................................................................................................................................................PHAYALFDLKFKK-GD---ILIKHRIDNNW--------------------FVGQANGQEGTFPINYVKVSVPLPMPQCI-----AMYDFKMGPNDEEGCL-STVIMRRVDHIFPIAFVELNAAAKKLLDSGLHTHPFCHPPKQQGQRALPPVPVIDPTVVTESSSGSSNSTPGSSNSSSTSSSNNCSPNHQISLPNTPQHVVASGSASVRFRDKGAKEKRHSLNALLGGGAPLSLLQTNRHSAEILSLPHELSRLEVSSSTALKPTSAPQTSRVLKTTVQQQMQPNLPWGYLALFPYKPRQTDELELKKGCVYIPGNYLTPLRARDQQQLMHQWKYVPQNADAQMAQVQQHPVAPDVRLNNMLSMQPPDLPPRQQQATATTTSCSVWSKPVEALFSRKSEPKPETATASTTSSSSSGAVGLMRRLTHMKTRSKSPGASLQQVPKEAISTNVEFTTNPSAKLHPVHVRSGSCPSQLQHSQPLNETPAAKTAAQQQQFLPKQLPSASTNSVSYGSQRVKGSKERPHLICARQSLDAATFRSMYNNAASPPPPTTSVAPAVYAGGQQQVIPGGGAQSQLHANMIIAPSHRKSHSLDASHVLSPSSNMITEAAIKASATTKSPYCTRESRFRCIVPYPPNSDIELELH 663
46 -10.800[T] KOG1701 Focal adhesion adaptor protein Paxillin and related LIM proteins  ali follow..  10  2.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SHPSWLPPKSTGEPLGHVPARMETTHSFGNPSISVSTQQPPKKFAPVVAPKPKYNPYKQPGGEGDFLPPPPPPLDDSSALPSISGNFPPPPPLDEEAFKVQGNPGGKTLEERRSSLDAEIDSLTSILADLECSSPYKPRPPQSSTGSTASPPVSTPVTGHKRMVIPNQPPLTATKKSTLKPQPAPQAGPIPVAPIGTLKPQPQPVPASYTTASTSSRPTFNVQVKS-AQPSPHYMAAPSSGQIYGSGPQGYNTQPVPVSGQCPPPSTRGGMDYAYIPPPGLQPEPGYGYAPNQGRYYEGYYAAGPGYGGRNDSDPTYGQQGHPNTWKREPGYTPPGAGNQNPPGMYPVTGPKKTYITDPVSAPCAPPLQPKGGHSGQLGPSSVAPSFRPEDE..... 392
47 -10.700[Z] KOG4462 WASP-interacting protein VRP1/WIP, contains WH2 domain  ali follow..  13  2........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................APAPPPPPPAPAPAAAAPAPPLMTGDRSALLNSIQKGKKLKKATTNDRSAPVVGGGVVGERKSNTPKSFAAPPVPTGAPSLPTSSNNTQQAEERPSMPALGGLFAGGMPKLRHIGKSSASAAPPSAPAPPTPQSELRPPTSAPPRPSIPPPSPASAPPIPSKAPPIPSSLPPPAQPAAPVKSPPSAPSLPSAVPPMPPKVPPPPLSQAPVANTSSRPSSFAPPAGHAPNVTSESPKFPNRGPSIPSASVPPVPPSSYVLQQRPNRVDDHGRFHFKDDSYLPIPHPFLGVPKVYRGGSGTTVPLNLSS............................................................................................................................................... 308
48 -10.600[D] COG5279 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain  ali follow..  6....................................................................................................................................................................................................................................................................................................TSLKPPFKVKARYGWSGQTK---------GDL-------------------FLEG--DI-MEVT----------RIAGSW--------------------F-------YGKL--------KKCSGHNFV-----------------------ILLEERLNSSTENGRQPSKIVESFEKSNKVVIPPVPSRYSDERPRPKKKLSSSMPNSPKKPVDSLTKARKAKSKEMVNEKNIYNTQSSRHHNNSAPNLPLASHSKPQVRNFEESMNNPLPPLPPLPDLDNMRKTDKRAPKKSYSANDLHMARSSREYNYYKDNQKFYDGFIPEKRYSLEEDSISSGLFSNSQYLNDSACSSENSFALMSDFSATSAGSFARHKYAQSFSDSLQRSQNANGCSTKINDSQEFGDSNASSRNGKMGDILRKIIIPKRNTNIYSSSVSSPKSPKAYPKLPDIQNLNLSATPDEARDWIAVKCHLNRARTLT...................................................................................................................................................................................................................... 393
49 -10.500[R] KOG4299 PHD Zn-finger protein  ali follow..  2...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DAKPWNHTSEAFQASILEDLKIIQKAGAERNAKSSHGSINSRSASPNKATSRRNRAQNGNSNGRASVDNSDDGSKDDLDYSPSVKRKHVNGEGAEKGDHDTSNNGPSITKLRRKVRRTYDTKDGFVAWNTLDDDFRPIVPDQERSRKINPQKGNNNNLLKENKSLKTTAKDLSDISSSSMKKANNSSKPLFSGKLTFKANIPVPTSEVVTENNVTRNVTVYSNQKHLGNES-----------ENFNDMEGRAEDISSNELLPTPEEYPYRYNNDYCSA. 268
50 -10.400[BK] KOG3001 Dosage compensation regulatory complex/histone acetyltransferase complex, subunit MSL-3/MRG15/EAF3, and related CHROMO domain-containing proteins  ali follow..  1.............................................................................................................................................................................................................................................................................................................................................................EASIKSTGEHY----------GW--NV------------RYDEWVK----------------------ADRIIWPLDKGGPKKKQKKKAKNKEDSEVDEKRDEERQKSKRGRPPLKSTLSSNMPYGLSKTANSEGKSDSCSSDSETEDALEKNLINEELSLKDELEKNENLNDDKLDEENPKISAHILKENDRTQMQPLETLKLEVGENEQIVQIFGNKMEKTEEVKKEAEKSPKGKGRRSKTKDLSLEIIKISSFGQNEAGSEPHIEAHSLELSSLDNKNFSSATEDEIDQCVKEKKLKRKILGQSSPEKENGMEMTNTVSQERTSDCIGSEGMKNLNFEQHFERENEGMPSLIAESNQCIQQLTSERFDSPAEETVNIPLKEDEDAMPLIGPETLVCHEVDLDDLDEKDKTSIEDVAVESSESNSLVSIPPALPPVVQHNFSVASPLTLSQDESRSVKSESDITIEVDSIAEESQEGLCERESANGFETNVASGTCSIIVQERESREKGQKRPSDGNSGLMAKKQKRTPKRTSAAAKNEKNGTGQSSDSEDLPVLDNSSKCTPVKHLNVSKPQKLARSPARISPHIKDGEKDKYYMSLKSEVATSHAGASMSSASSDTGMSPSSSSPPQNVLAVE 663
51 -10.400[DK] KOG4333 Nuclear DEAF-1 related transcriptional regulator (suppressin) and related SAND domain proteins  ali follow..  326.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................NQVEQGEEQFLYTLTDLERQLEEQKKQGQDHRLKSQTVQNVVLMPVSTPKPPKRPRLQRPASTTVLSPSPPVQQPQFTVISPITITPVGQSFSMGNIPVATLSQGSSPVTVHTLPSGPQLFRYATVVSSAKSSSPDTVTIHPSSSLALLSSTAMQDGSTLGNMTTMVSPVELVAMESGLTSAIQAVESTSEDGQTIIEIDPAPDPEAEDTEGKAVILETELRTEEKVVAEMEEHQHQVHNVEIVVL............................................................................................................... 571
52 -10.400[S] KOG4556 Predicted membrane protein  ali follow..  162..............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KPIRSNSQSINHYAQICASKVAKAPSSTNNSSSGYLNSQYDDLGSSREKVKVTEKKEVKGQFERNSKKKKKNPRPEMPAPDCAPCSSNRSSEEESNLEDVYTQPIKKKIMPLRRPDLEEENRGTNVTSLVSFDPKSATLLRIRQHLEAEPSDRDTPDYDMYERLRSRSSGHSEVAPASTIPLSSDYKSRNASQDSVPSMFAPMLNSPAPSSTTSGSSSRTSGASLAHKTHIVGKGGISLSTVDPSPILSPGIRLSEQLGAKNQSYKSAFRVQKTENARVISHYHAPNEIPLSSDPSVVENESNYPVMTSGG..................................................... 472
53 -10.200[R] KOG2789 Putative Zn-finger protein  ali follow..  224.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................NPKLTPFSFNNNPDTLPSNIAPMGTLSKSSLPLHHIPWPPNQHIKFAHDDKNVVSTDFIHPDWQYKLERARRRALRRAANATLLNSHLLETGPANANANHNTDLSHDPTSHGGPRRTLSSRRQHYLANVEQLMLAEAIRQSLLDAQSNDSTNSLPSTEVSQPDSTNISNEQEIVQPQPTHTTNVALVEEINRPDSVESAITASSSIDTGNENETQEVNSDSLPQFVHQTMTQTNFQESSPSVAADETRVHNVDEYIEQQDLDELIHSPIASTNPFLADQFARSETVDLNAHICSPALSVSDDGVTATNKTQSSFPSVYEHQLKSNELERG....... 553
54 -10.100[NU] COG3170 Tfp pilus assembly protein FimV  ali follow..  11  28..........................................................................................................................................................................................................................................................................................................LLLIQPAAHAGFGALHVRSS-----------------------QPL---QAEIDLSGVTEE------------------QNLVAKLASPDAYQR---------AGLT-LRASLVRQSGGSYVV-PVAEPFVDILVDLTWASGRVSRAYTF-----LLDPAGSSNTPRNFAPTPVVQATTPGVVDSTPAPVAAAPQAPAAAPRAARPARQAAVRPQADAAAAEPSSGAGYTVQRGDS-------------------ASNAVQGQDGVSLDQMLLALYRNNPKA---GGNINRLRTGSVLTVPSAAEAQKVSSREARREVVAQTSG----------------------------AGYRSRLATAAEANAATDTDSARQQSGSVSARVQDQATPSASERDELRLSKADRTGKAAATAGARAEELVAKEHALKEMESRVAQLEKNLSEMQHLIEVKNAELAKAAAAKPAAGAAPSPATAAPAVTAANAPAPSASASATPAQAPAAAASSAETASSATATAGASAPAAATPAAASAPVAEASAPAAAPRKAPVVVAPQPPAEEESFFSSLLGNPMALGLGGLVVALAGGLAVYRRRQQKPEQAHGFQDSLLSQESTVMAGANSLFGAAGGQSIDTSQHSVFGADFRIGGGNESNEVDPIAEADVYIAYGRDVQAEEILREALEQHPERAIRLK 631
55 -10.100[K] KOG4661 Hsp27-ERE-TATA-binding protein/Scaffold attachment factor (SAF-B)  ali follow..  1..............................................................................................................................................................................................................................................................................................................MAETLSGLGDSGAAGPAALSSASS------------------TGTR-DLRVIDLRADVR---KRNVD---SSGNKSVLMERLK------------------------KAIE-DEG-------------------GNPDEIEITSEGNKKTSKRSSKGRKPEEEGVEDNGLEENSGDGQEDVETSLENLQDIDIMDISVLDEAEIDNGSVADCVEDDDADNLQESLSDSRELVEGEMKELPEQLQEHAIEDKETINNLDTSSSDFTILQEIEEPSLEPENEKILDILGETCKSEPVKEESSELEQPFAQDTSSVGPDRKLAEEEDLFDSAHPEEGDLDLASESTAHAQSSKADSLLAVVKREPAEQPGDGERTDCEPVGLEPAVEQSSAASELAEASSEELAEAPTEAPSPEARDSKEDGRKFDFDACNEVPPAPKESSTSEGADQKMSSPEDDSDTKRLSKEEKGRSSCGSGLSSTTRATDLKNLFSKYGKVVGAKVVTNARSPGARCYGFVTMSTAEEATKCINHLHKTELHGKMISVEKAKNEPVGKKTSDKRDSDGKKEKSSNSDRSTNLKRDDKCDRKDDAKKGDDGSGEKSKDQDDQKPGPSERSRATKSGSRGTERTVVMDKSKGVPVISVKTSGSKERASKSQDRKSASREKRSVVSFDKVKEPRKSRDSESH.... 620
56 -9.950[T] KOG4688 Putative beta-catenin-Tcf/Lef signaling pathway component DRCTNNB1A  ali follow..  291.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TSAVRNSLHANPSGQPNDGPMGLSVALTPSTTTVTTSVSKSMITNASFRTKKLPDDIPIQVQDLTIQQAPQQLASVTEETEPGTKESPSTKESSGTRTSIMRPSMEGIKAQAHKALIAGFKKSKDKEKEKDKEPPKPPQRKFDKHTQRNSLLQLQAEPSSNSSAEQPPTGEVLPLQTLSLINENGSNSFSVDSDLNDGVLGVSANTSLPPLSSTTNSVTSSDLITKSFDSSIELAPIGHSSSNGGKLAEHGLAE....... 544
57 -9.940[B] KOG4140 Nuclear protein Ataxin-7  ali follow..  12  347......................................................................................................................................................................................................................................................................................................................................................................................................................CGV--IDLDTKKPCTRSLTCKTHSLTQRRAVQGRRKRFDVLLAEHKNKTREKELIRHPDSQQPPQPLRDPHPAPPRTSQEPHQNPHGVIPSESKPFVASKPKPHTPSLPRPPGCPAQQGGSAPIDPPPVHESPHPPLPATEPASRLSSEEGEGDDKEESVEKLDCHYSGHHPQPAS-----CALNLMVEKHLNAQLWKKIPPVPSTTSPISTRIPHRTNSVPTSQCGVSYLAAATVSTSPVLLSSTCISPNSKSVPAHGTTLNAQPAASGAMDPVCSMQSRQVSSSSSSPSTPSGLSSVPSSPMSRKPQKLKSSKSLRPKESSGNSTNCQNASSSTSGGSGKKRKNSSPLLVHSSSSSSSSSSSSHSMESFRKNCVAHSGPPYPSTVTSSHSIGLNCVTNKANAVNVRHDQSGRGPPTGSPAESIKRMSVMVNSSDSTLSLGPFIHQSNELPVNSHGSFSHSHTPLDKLIGKKRKCSPSSSSINNSSSKPTKVAKVPAVNNVHMKHTGTIPGAQGLMNSSL........................................................... 884
58 -9.900[S] KOG4351 Uncharacterized conserved protein  ali follow..  75.......................................................................................................................................................................................................................................................................................................................................................FVDENLD------GTHLTKFIKH-----WR-NTGNV------------KWSADTKLKFWG-KDVLVPCL--KAGHVGVVSVE-SHWRLSHKGQQFGPRVWCSIIVDPFPSEESPDNIEKGMISSSKTDDLTCQQEETFLLAKEERQLGEVTEQTEGTAACIPQKAKNVASERELYIPSVDLLTAQDLLSFELLDINIVQELERVPHNTPVDVTPCMSPLPHDSPLIEKPGLGQIEEENEGAGFKALPDSMVSVKRKAENIASVEEAEEDLSGTQFVCETVIRSLTLDAAPDHNPPCRQKSLQMTFALPEGPLGNEKEEIIHIAEEEAVMEEEEDEEDEEEEDELKDEVQSQSSASSEDYIIILPECFDTSRPLGDSMYSSALSQPGLERGAEGKPGVEAGQEPAEAGERLPGGENQPQEHSISDILTTSQTLETVPLIPEVVELPPSLPRSSPCVHHHGSPGVDLPVTIPEVSSVPDQIRGEPRGSSGLVNSRQKSYDHSRHHHGSSIAGGLVKGALSVAASAYKA..................................................................................................................... 599
59 -9.860[S] KOG1181 FOG: Low-complexity  ali follow..  257.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................ESQNQPAIKIKQEPVDYAPEATVMTTIPMTQFESSLNESERSEEVDEAMIQSQEDVKPNRMELDRMMQISNVTSGVDMAEEAMALERAEEACPEDSLHKVKSVKSTARKSTGGAERKTYSPPRTNTLPQIVAVVSGESAFNMISIKPEPRNLGYGDEEPEDQRETTEEINHNDMMEEEKEYIGSLDLSDVSVKQERELDICEIDAVHRNGLEKSDEDDDDGNEDSASSADEAEEAMERDTEERIYREIELPPLELQNESSRKDLESERMDTEVSTALPASETPSQTRDVLGVEKSEASAFSLVITNICSQAVPQPSAACSNDIECSIGPSPSTTNEPHSHTVENVQSPANDLQTSAQVAIAAQSQPDPCIVSQPAASSESQADTKDLPPAASQIQTFNTESLPIHVHSETEDNSIENDASYLESRAQVDCQSAGTENPSVVLEQNESLPSGSCVSPIPENPSPGNSPPQHDESESLDKPEMAAGSAYCLATVSLDAPKDTEALALPPCDAAIIDSNYTSDEEQQN.... 781
60 -9.840[S] KOG3930 Uncharacterized conserved protein  ali follow..  10  1...........................................................................................................................................................................................................................................................................................................................................................................MSKSSAARW-NAAG-----PSPAAAGY-------AHVFVENRI---DMLLDLN-KEYLREM---GITLMGD-------IIA--ILRHSKTV----------EQNAREQVLTTEVVQSVVRPVSPKPKAPVATPKAKVYPPAKPARRVLPEHEGKYKVTLPSGTTERSKQILAKREKLYSDRVSSSKKSDIFTRLHAEDEAQEGIVSSSGESSVRVHVAGASKTAATSSNNSVFARLGGKQGALPEEFTSTREIKSILKNTHRTVGGGGGGGGVTKNSPIVKAKKVAAVTQQKVMLVHKVPLKKGDDDDDSMDDFESDEEDYMSSGEDFDMGAGEKIVKFASTAEVREIVPESAYKNRQGKSFANNIKSRLGMVSKLHATKKTYNLKASPARKPQARLSPVKGKTIRMRSDELFSRQDTVPVHRRLGKTATSAPLRAPPAPPHRQPRPEPQKKYVPPRRHNSMNAGHSRQRDQSGSVFDRLGFNNS.......................................................................................................................................... 454
61 -9.820[R] KOG0562 Predicted hydrolase (HIT family)  ali follow..  262.......................................................................................................................................................................................................................................................................................KRNFLIESDRAVVMKADYPRVVAKEE--RDITQLTEAQLPLLDHMMDLANQIIEKQKHLESRNTFWN---RLNLHVISNDF-----------------SMAMK------RISHWNSFNTELF--MPFQIAYMMLSVQGS----------IESISEETYNNLQEKTPLRCNQCEFVTNMLLDLKAHLYQHWQRKEDERDQKKKVDKIIQMISETKLDEAEAKPKLLNEEEPIQAQPVAAIAQYPNEHLGKPLTPQQQPGKQQAQNVYDKNINGPSVNMMNQNNPNNPFRNTPHLNRQSQKPPHPRSGPRGPMAPWTGPRFPCHQQQNRFRPPGFNACRQPYPPYHSGHQQFPNASSVGGGQTGLPGQGQGPRPKWNSNKIFNQQNRQNTVQAQPQAQNQQTNQQQIQNSNKNQTPKKKPWKNRLQPVGKVQNQGGANRDPAPPSNSKPS................................................................................................................................................................................................................................................................... 685
62 -9.790[S] COG3266 Uncharacterized protein conserved in bacteria  ali follow..  11.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KPDPSDRRTGRSRQSSERDSEPQINFDDVDLDADDRRPTRTRKARSEEPEVEEEYESDEDDTVDEERVERRPRKRKKAAHKPASRQYMMMGVGVLVLLLLIIGIGSALKAPSTSSSEPSASGEKSIDLSGNAADQANATQPAPGATSAEQTAGNTSQDISLPPISSTPTQGQSPVVADGQQRVEVQGDLNNALTQNPEQMNNVAVNSTLPTEPATVAPVRNGSTTRQAAVSEPAERHTTRPERKQAVIEPKKPQTTAKTTTAEPKKPVAPVKRTEPAAPAATPKATTTTAAPTATASAAPVQTAKPAQASTTPVAGGGKSAGNVGALKSAPSSHYTLQLSSSSNYDNLNG........................................................... 360
63 -9.730[S] KOG4623 Uncharacterized conserved protein  ali follow..  356.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SGYAMGIEFLDPYISGISFILVGSFVTLVLLATNRTNLLSQVNRDESACESFHRLCADECDDETLSMLSQQLSGYSDISNSNLSMRTASVCHSPAPTISQRTIQAPASLLSLDSLHLSKQRMEQQAWSSNYGDASTVVAPRVQPAMMFQQKPMRPLESQWYRHGQSNLAQGNTFTRSTQNLLMPSRLPSINRNVGGADVSAWVAANQSVNQDLCTANLMRHYEEKQQNQLSRTSSQSSGFESQPRPEAQCGTGAATVRDYGWSEARESQRNFAVFPPMPSPTPTITPSEYQYSRTALPQQQPTMQPGD..... 663
64 -9.650[KTDL] KOG2043 Signaling protein SWIFT and related BRCT domain proteins  ali follow..  19.......................................................................................................................................................................................................................................................................................................................................................YAVGDIDPQVIQLKAKEVSYNALAISEDGDNPEVGEAREVFDLPVVKPSWVILSCQIFFGITACALWALVTFYGGDCQLTLNKKCTHLIVPEPKGEKYECAKIVTPDVLDCVSEKTKKDEAFYHPRLIIYEEEEEEEEEEEEVENEEQDSQNEGSTDEKSSPASSQEGSPSGDQQFSPKSNTEKSKGELMFDDSSDSSPEKQERNLNWTPAEVPQLAAAKRRLPQGKEPGLINLCANVPPVPGNILPPEVRGNLMAAGQNLQSSERSEMIATWSPAVRTLRNITNNADIQQMNRPSNVAHILQTLSAPTKNLEQQVNHSQQGHTNANAVLFSQVKVTPETHMLQQQQQAQQQQQQHPVLHLQPQQIMQLQQQQQQQISQQPYPQQPPHPFSQQQQ........................................................................................................................................................................................................................................................ 453
65 -9.620[K] KOG2261 Polycomb enhancer protein, EPC  ali follow..  135............................................................................................................................................................................................................................................................................................................................CPLQFEEMIDRLEKGSGQQPVSLQ-DELIREVYEYWIKK-NDPYVAFRRRTEKMQTRKNNDEASYEKM----KLRRDLSRAVTI--------LEMIKRRE-KRELLHLTLEIM--------EKRYNLGDYNGEIMSEVMAQRQPMKPTYAIPIIPITNSSQFKHQEAMDVKEFKVNKQDKADLIRPKRKYEKKPKVLPSSAAATPQQTSPAALPVFNAKDLNQYDFPSSDEEPLSQVLSGSSEAEEDNDPDGPFAFRRKAGCQYYAPHLDQTGNWPWTSPKDGGLGDVRYRYCLTTLTVPQSDYDSVFHHLDLEMLSSPQHSPVNQFANTSETNTSDKSFSKDLSQILVNIKSCRWRHFRPRTPSLHDSDNDELSCRKLYRSINRTGTAQPGTQTCSTSTQSKSSSGSAHFAFTAEQYQQHQQQLALMQKQQLAQIQQQQANSNSSTNTSQNLASNQQKSGFRLNIQGLERTLQGFVSKTLDSASAQFAASALVTSEQLMGFKMKDDVVLGIGVNGVLPASGVYKGLHLSSTTPTALVHTSPSTAGSALLQPSNITQTSSSHSALSHQVTAANSATTQVLIGNNIRLTVPSSVATVNSIAPINARHIPRTLSAVPSSALKLAAAANCQV----SKVPSSSSVDSVPRENHESEKPALNNIADNTVAMEV. 835
66 -9.600[A] KOG4849 mRNA cleavage factor I subunit/CPSF subunit  ali follow..  97...................................................................................................................................................................................................................................................................................................................................................................VGN------------TW-------------TTDQ----IANSLRDIGVSDLQEVKFFENRNGQ-------SKGFSVISLGSESSLRAVLDQLPKKEMHGQAPVVTYPSKQALTQSLQKTRPVPPPQQNGPPRGPAPPSMGGGPMPTGHPGGPQGGGPPGHPPRGMNSIMQPGQYRPQHMSQVPQVGGPNSGPPRMQPPMHPQGGLMGNQQPPPRYPSAQGQWPGQRPGGPRPGPPNGPPQRPMFQGGPMGMPVRGPAGPDWRRPPMHGGFPPQGPPRGLPPAPGPGGPHGAPAPHVNPAFFNQPGGPAQHPGMGGPPHGAPGPQPGMNMPPQQGMNMTPQHGPPPQFAQHGPRGPWPPPQGKPPGPFPDPQQMGPQLTEVEFEEVMSRNRTVSSSAIARAVSDAAAGEYSSAIETLVTAISLIKQSKVAHDERCKILISSLQDTLHGIEAKSYNRRERSRSRERSHRSRQRRERSTSRYRERSRERERDRDRERERDGGRSVRPRKSPEPVVAEAAEAPSSKRYYEDRERYRSSDRERRDRDRDRDRERERDRDRHFTNDGRGLPLDPSNFTSQNPGNIKTGRPKSAAVAGGSMEKPRGQSAWDIIDTDAHKQQTTSIPAPPSSQQNFNI. 699
67 -9.560[D] KOG2398 Predicted proline-serine-threonine phosphatase-interacting protein (PSTPIP)  ali follow..  166..........................................................................................................................................................................................................................................................................................................................................................SKVELKVARAREEYKSYVDKLVREDFETK------------------MSDSCKKFQTFDRSLYASI-----QQFMANHSTEMSSASHQVAEQFKESIQHLNADEFVRKFVKTKSTGTEKPPRVLFEESENGQLPASSSSMNLNPVRDLVDIMSGNSMPSSCSSSGILQDQAPPPHPTTVDLLMMDPIGEGIPVVDSSINSNYSTPPIINNSIPESIKKSSEDLSEKKGGKKLSMFIPKRRTKTVSTSSIDETPTTAEPFSASGLFKFTREKRRSKKENEANLRASVCMDDTHSTASSSKSDDKMLNGSAPAHSLLDAPIDEKPKNLPVVDDEGYIVRTTTTSENNADSSNPTAWSSCSSDEEEDEDELQKSRIRKMTISDRPVHINASVDELR-----DAIGSITLTRSTTFERDPWTIGGTKAPLMFSQSMNVSSLRQPLRSHHTADGRFRTNFSESEDPPAFSVSMGHNQAMAAGIARARPRSNTPTTSQMMSRKDSASSFMDPWSSTFNLAPSESNHSLGESTFNLSQSTGNLLQATISEQRIPLAMAINEHVHVWFKKGAEEFIQRTFGTVMISFPTSSITLLTSIQHEIEPLAF------SNAKFIKSVLPNKQLIDENVSKKDDEMCIFYFNKT 778
68 -9.500[R] KOG3175 Protein phosphatase 4 regulatory subunit 2 related protein  ali follow..  132......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................VSCVYPSSEKNNSNSLNRMNGVMFPGNSPSYTERSNINGPGTPRPLNRPKVSLSAPMTTNGLPESTDSKEANLQQNEEKNHSDSSTSESEVSSVSPLKNKHPDEDAVEAEGHEVKRLRFDKEGEVRETASQTTSSEISSVMVGETEASSSSQDKDKDSRCTRQHCTEEDEEEDEEEEEESFMTSREMIPERKNQEKESDDALTVNEETSEENNQMEESDVSQAEKDLLHSEGSENEGPVSSSSSDCRETEELVGSNSSKTGEILSESSMENDDEATEVTDEPMEQD...... 417
69 -9.460[TZ] KOG3671 Actin regulatory protein (Wiskott-Aldrich syndrome protein)  ali follow..  10  25....................................................................................................................................................................................................................................................................................................................................................................................PPNVGSKELNSQEVGSEAVCLTAAVVQLL-GV----ISLVKDYAQRAYFLRIFDLEERIVWDFKEYEAAEFKEHLERRHAQERKSTSTTRPAHPGMPIVVSSGIGSTPTRQFEIT-------QAYGGTIRGPPMAIGGGQGITQMGTMAAAPQSHTHTDGNASSSGSWFRKDKNKKKDKKSKIKKEDISNPTNFQHKAHVGWNQDSGFSNTVYDDDMDEANILKAAGLESNNLNEDDKKFVKKFIAKNYDKYVSVGSLDPSQISSPLPPPIQQHPQMNQSWNQTPVRQYKPSFPSSAPIGSGASSYSTPAAPPPPTRVESHGLAPARPPPPPPSSGTRGIAPSRPLPQAPNYGTPENRPHAVPPPPPPPPPQSFGMAPISSAAPPPPPPPPPMGLPAVGAGAPPPPPPPPPSGAGGPASVLAKLPPAQDGRSNLLAEIQAGKQLRSVQQTADSPKSAGGDARGDVMAQIRQGAQLKHVDAAAEQERRKSTTSGAAGMGGLAGALAKALEERRMNMGIDDTSDDDDDEDDK.................................................................................... 602
70 -9.390[F] COG0027 Formate-dependent phosphoribosylglycinamide formyltransferase (GAR transformylase)  ali follow..  11  5.................................................................................GTPLTPKATKVMMLGSGELGKEVVIELQRL--GVEVIAVDRY-ANAPAQQVAHRAYTISMLDGEALKALVEKEKPDYIVPE----------TATLVELEQAGFTVIPTAKATQLTMNREGIRRLAAE------ELGLPTSNYQFVDNFDDFKRAVEKI--------------------------------------------------------GIPCVVKPIMSSSGHGQSILKSVEQIPSAWEYAQQGGRAGAGRVIVEGFVKFDYEITLLTVRHVHGTSFLAPIGHIQIDGDYRESWQPQAMSAVALEKAQAIAGALGGRGIFGVEMFVCGDE--IFNEVDTGMVTLISQELSEFALHARAIL........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 308
71 -9.380[KD] COG5189 Putative transcriptional repressor regulating G2/M transition  ali follow..  4.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TTMTMASNMATSTTTTATSAHASINSSSNFNIDIDSNQNTPSILINNNSDSSNGKNTDFNGVNNIHQKNIMNNTNNVHLYSPNIMDQTLLTPQDIAKLRRESIAHSQGMGGVSGSISVGSWLRDEIISRRNSIVPASANGAASAAASATTTATNTLQIQQPTKRPSVSNPPYHRGYSISPQIAYTASPNTTNMSQIPMNSAGNTSSSVRMTNNTSSANYNLQNNMAANTKNAGHKTNTMQAHSSNATNNTSINNMHANLQSNMDSNSTIRQSQHPHHQQNIIQQQLQSNSVNHTSGAVPTPSVMGSATASSTTANPNVISITGAPNSGLSMANHSQQLHLNGNLVDAVSTNDVFLRTSNSPSRHVPHNKQINSNNNSGININNNTSHNSNINMGSKNAMVNRPHTFNNYSLNKTSRNPIQHQSRKIDPHQTDLSPLVLVQDID...... 484
72 -9.330[R] KOG4433 Tweety transmembrane/cell surface protein  ali follow..  10  416....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ASNAPSASISPTAPLSTGTINRTLLHHQQASSGGGSGTLPGSGGGAGAGGGVGANGHNGVGPYRNGSAGLRQGLASPSSQSSHTSSTATYNNGTTSYHNSHQQHNNHLYSNHYSHSNNHYNNTQHRTNPAAGAVAAAVGVVSSGQRSPSPPPVYDLDAFHRTTSNRRRICQDPTMESSSSNTAQQQQQNLQLQQHQQQSNLINQNQSQSTLKNIFASATLPRSTGSSIRSVLSVQTSNAGICRSTGNGLDGDMVDDRDPRDVTNNSFNRFDPKYISIGPKAVRGQNNN--------LNIMSVAGGANKCATLRHVGRYGGSLKGVSAVNATPSPAAAPAVHSPNLRSAKTPSIATVSK................................................ 765
73 -9.300[A] KOG2937 Decapping enzyme complex, predicted pyrophosphatase DCP2  ali follow..  18.......................................................................................................................................................................................................................................................................................................RF--ILNL----SSVERLQIEQAH-YEDF----QLPSLGLRVFSAK-PLL-WKWSKVHEEAFDDFLRYKTR----------GAIMLQQCVLVKGWKAW--------GKID-CAIREVYEETGFDYIIPGISLDTRFESRTRKEISKILMDLFLAPLKKWIKKRNIANNTTKEKNISVDVDADASSQLLSLLKSSTAPSDLATPQPSTFPQPPVESHSSFDIKQKILHLLNEGNEPKSPIQLPPVSNLPLNPPIQSSNSRLSHDNNSFDPFAYLGLDPKNPSASFPRVVSQNNMLTNKPVLNNHFQQSMYSNLLKDQNSVQHLFAASDMPSPMELPSPSTVYHQVFYPPTSTSVSSYGLGKTPQPAYGSSSPYVNGHQTQQISSLPPFQSQTQFLARNSDNSGQSYNSEGDSNSKRLLSMLSQQDTTPSSSTLSKEANVQLANLFLTPNSLETKKFSDNSQGEEISDNLHGESCNNPNANSVHSAQLLQALLHPSATETKEETPKKTSDSLSLLTLLKSGLPTPANDLQNKSQNNERKASSQVKELEVKNYSKSTDLLKKTLRIPRNDEPLEAANQFDLLKVSPQQKSEVPPKRNELSQSKLKNRKKKENSETNKNHVDMSPGFVKILKRSPLADQKKEDTQESDFKG-------SDDHFLSYLQSVVSSNSNGL................. 740
74 -9.190[K] KOG2652 RNA polymerase II transcription initiation factor TFIIA, large chain  ali follow..  5.................................................................................................................................................................................................................................................................................................................................................................NPVPKLYR-----------------SVIEDV---------IEGVRNLFEGIE---------------------------------------EQVLKDLKQL---------------ETKVLQSKATEDFFRNSIQSPLFTLQLPHSLHQTLQSSTASLVIPAGRTLPSFTTAELGTSNSSANFTFPGYPIHVPAGVTLQTVSGHLYKVNVPIMVTETSGRAGILQHPIQQVFQQLGQPSVIQTSVPQLNPWSLQATTEKSQRIETVLQQPAILPSGPVDRKHLENATSDILVSPGNEHKIVPEAL---LCHQESSHYISLPGVVFSPQVSQTNSDVESVLSGSASMAQNLHDESLSTSPHGALHQHVTDIQLHILKNRMYGCDSVKQPRNIEEPSNIPVSEKDSNSQVDLSIRVTDDDIGEIIQVDGSGDTSSNEEIGSTRDADENEFLGNIDGGDLKVPEEEADSISNEDSATNSSDNEDPQVNIVEEDPLNSGDDVSEQDVPDLFDTDN.......................................................................................................................... 435
75 -9.100[L] KOG2310 DNA repair exonuclease MRE11  ali follow..  245...........................................................................................................................................................................................................................................................................................................FIVWGHEHE--GSSVATSLIDGESKPKHVLLLEIKGNQY-SILEHLDKVVRVRIKVDYSGFMTINPQRFGQKYVGKVANIFSKASKKGRSEANIDDSERLRPEELNQQNIEALVAESNLKMILPVNDLDVALHNFVNKDDKLAFYSCVQYNLQETRGKLAKDSDAKKFEEDDLILKVGECLEERLKDRSTRPTGSSQFLSTGLTSENLTKGSSGIANASFSDDEDTTQMSGLAPPTRGRRGSSTANTTRGRAKAPTRGRGRGKASSAMKQTTLDSSLGFRQSQRSASAAASAAFKSASTIGEDDVDSPSSEEVEPEDFNKPDSSSEDDESTKGKGRKRPATTKRGRGRGSGTSKRGRKNESSSSLNRLLSSKDDDEDEDDEDREKKLNKSQPRVTRNYGA............................................................................................................................................................................................................................................................................................... 717

FFAS is supported by the NIH grant R01-GM087218-01
1 4 8 0 9 9   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Ye Y, Jaroszewski L, Li W, Godzik A. A segment alignment approach to protein comparison. Bioinformatics. 2003 Apr 12;19(6):742-9.